Perform Another (Advanced) Search

1.  Newly Approved Drug Therapies (725) Adderall XR, Shire Pharmaceuticals,
...Newly Approved Drug Therapies (725) Adderall XR, Shire Pharmaceuticals, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Adderall XR Company: Shire Pharmaceuticals Approval Status: Approved October 2001 Treatment Area: Attention deficit/hyperactivity disorder ...
View Page

2.  Newly Approved Drug Therapies (59) Adderall (mixed salts of a single-entity amphetamine), Richwood Pharmaceutical,
...Newly Approved Drug Therapies (59) Adderall (mixed salts of a single-entity amphetamine), Richwood Pharmaceutical, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Adderall (mixed salts of a single-entity amphetamine) Company: Richwood Pharmaceutical Approval Status: Supplemental NDA Approved ...
View Page

3.  CenterWatch: New Medical Therapies in Disease Category (499), Attention Deficit/Hyperactivity Disorder (ADHD - Adults)
...Shire issued positive results from two phase III trials, dubbed study 201 and 203, of Adderall XR (SDP465) for the treatment of adult Attention Deficit/Hyperactivity Disorder. In both trials subjects received Adderall XR or placebo at doses of 25, 50 or 75 mg during three, seven day ...
View Page

4.  Newly Approved Drug Therapies (942) Vyvanse (Lisdexamfetamine Dimesylate), New River,
...the DSM-IV criteria for ADHD. Following a 3-week open-label dose titration with Adderall XR, subjects were randomly assigned to continue the same dose of Adderall XR (10, 20, or 30 mg), Vyvanse (30, 50, and 70 mg), or placebo once ...
View Page

5.  CenterWatch: New Medical Therapies in Disease Category (18), Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)
...0001). These results were non-inferior to those observed in subjects receiving approved therapy with Adderall XR, vs. placebo. This double-blind, placebo- and active- controlled, randomized, 3-treatment, 3-period ...
...52 children (ages 6-12) with ADHD, who received one of 3 regimens of NRP104, Adderall XR, or placebo. October 28, 2002 Celltech reported positive preliminary results from a comparative phase ...
View Page

6.  CenterWatch: Psychiatry/Psychology Approved Drug Therapies
...the treatment of premenstrual dysphoric mood disorder (PMDD), Approved May 2002 Drugs Approved in 2001 Adderall XR ; Shire Pharmaceuticals; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD ...
...Sustained-Release Tablets ; GlaxoSmithKline; Treatment for smoking cessation, Approved May 1997 Drugs Approved in 1996 Adderall (mixed salts of a single-entity amphetamine) ; Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder ...
View Page

7.  CenterWatch: Pediatrics/Neonatology Approved Drug Therapies
...Deficit/Hyperactivity Disorder (ADHD) in children, adolescents and adults., December 2002 Drugs Approved in 2001 Adderall XR ; Shire Pharmaceuticals; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD ...
...of panic disorder in children ages 6-17, Approved October 1997 Drugs Approved in 1996 Adderall (mixed salts of a single-entity amphetamine) ; Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder ...
View Page

8.  Study Posting (2348) Trial #53935, Attention Deficit/Hyperactivity Disorder (ADHD - Adults), New York, NY
...blood pressure Cannot participate if pregnant or breastfeeding. No exposure to stimulant medication (like Ritalin, Adderall, Dexedrine) within past 6 months. Participants with ADHD: No previous treatments for ADHD except for ...
View Page

9.  CenterWatch: List of Newly Approved Drug Thearapies
...2% (mupirocin calcium ointment) ; SmithKline Beecham; Treatment for nasal bacteria, Approved April 1996 Pediatrics/Neonatology Adderall (mixed salts of a single-entity amphetamine) ; Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder ...
...Cyanocobalamin, USP) ; Questcor Pharmaceuticals; Treatment for vitamin B-12 deficiency, Approved November 1996 Psychiatry/Psychology Adderall (mixed salts of a single-entity amphetamine) ; Richwood Pharmaceutical; Treatment for attention-deficit/hyperactivity disorder ...
View Page

10.  CenterWatch: List of Newly Approved Drug Thearapies
...For the treatment of cytomegalovirus retinitis in patients with AIDS, Approved March 2001 Pediatrics/Neonatology Adderall XR ; Shire Pharmaceuticals; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD ...
...counter nasal spray for treatment of all nasal allergy symptoms, Approved April 2001 Psychiatry/Psychology Adderall XR ; Shire Pharmaceuticals; Once-daily medication for the treatment of attention deficit/hyperactivity disorder (ADHD ...
View Page